AstraZeneca PLC (AZN)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
13,288.00p
Buy
13,294.00p
-337.4009p (-2.47%)
Prices updated at 19 Nov 2026, 16:50 GMT
| Prices minimum 15 mins delay
Prices in GBX
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| 13,672.00p - 13,274.00p | |
| 15,732.00p - 9,892.00p | |
| 1.71 | |
| 211,638.23m | |
| 25.52 | |
| 150 | |
| 1,748,659 | |
| 5.40 | |
| 2,652,877.46 | |
| 1.36 | |
| 1,550.91m | |
| GB0009895292 | |
| 6.54 | |
| 1.32 |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.